Jeffrey Barkun, MD, MSc, FRCS, FACS - Jeffrey Barkun, MD, MSc, FRCS, FACS - Research Institute MUHC
My research focuses on the discussion of the bile duct, liver and pancreas for patients who suffer from cancer or have had a liver transplantation.
Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ration with the McGill Brisbane Symptom Score. Dumitra S. Jamal MH. Aboukhalil J. Doi SA. Chaudhury P. Hassanain M. Metrakos PP> Barkun JS. HPB. 15(12):1002-9, 2013 Dec.
Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20 year experience. Dumitra S. Alabbad SI. Barkun JS. Dumitra TC. Cotsinos D. Metrakos PP. Hassanain M. Paraskevas S. Chaudhury P. Tchervenkov JI. HPB 15(9):724-31, 2013 Sep.
IDEAL Framework for surgical innovation 2: observational studies in the exploration and assessment stages. Ergina PL. Barkun JS. McCulloch P. Cook JA. Altman DG. IDEAL Group, BMJ.346:f3011,2013
The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Slankamenac K. Graft R. Barkun J. Puhan MA, Clavien PA Annals of Surgery. 258(1):1-7, 2013 Jul.
Anti CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. Walsh C. Barkun J. Tchervenkov J. Deschenes M. Ghali P. Wong P. Chaudhury P. Paraskevas S. Metrakos P. Cantarovich M. Transplantation. 95(3):495-500, 2013 Feb 15.